ReAl-life Multicenter Survey Evaluating Stroke prevention strategies in non-valvular atrial fibrillation (RAMSES study)

Basaran, Ozcan; Beton, Osman; Dogan, Volkan; Tekinalp, Mehmet; Aykan, Ahmet; Kalaycioglu, Ezgi; Bolat, Ismail; Tasar, Onur; Safak, Ozgen; Kalcik, Macit; Yaman, Mehmet; Altun, Ibrahim; Soylu, Mustafa; Kirma, Cevat; Biteker, KADİR

doi:10.14744/anatoljcardiol.2016.6752

ReAl-life Multicenter Survey Evaluating Stroke prevention strategies in non-valvular atrial fibrillation (RAMSES study)

Basaran O., Beton O., Dogan V., Tekinalp M., Aykan A. C., Kalaycioglu E., ...Daha Fazla

ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.16, sa.10, ss.734-741, 2016 (SCI-Expanded, Scopus, TRDizin)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 16 Sayı: 10
Basım Tarihi: 2016
Doi Numarası: 10.14744/anatoljcardiol.2016.6752
Dergi Adı: ANATOLIAN JOURNAL OF CARDIOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.734-741
Anahtar Kelimeler: atrial fibrillation, stroke, prevention, oral anticoagulant therapy, ANTITHROMBOTIC TREATMENT, ANTICOAGULANT TREATMENT, INFORMED TREATMENT, OUTCOMES REGISTRY, RISK-FACTORS, WARFARIN, EPIDEMIOLOGY, POPULATION, MANAGEMENT, ASPIRIN
Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Objective: Data regarding stroke prevention strategies in non-valvular atrial fibrillation (NVAF) are limited to vitamin K antagonists (VKAs). This study aimed to evaluate real-life stroke prevention strategies for NVAF patients in the era of non-VKA oral anticoagulants (NOACs).